COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,892 Articles (22,568 medRxiv, 8,324 bioRxiv)

Most recent first Previous |  Page 1817: Articles 18161-18170  | Next

COVID-19 mortality: positive correlation with cloudiness and sunlight but no correlation with latitude in Europe
Omer, S., Iftime, A., Burcea, V. A.
10.1101/2021.01.27.21250658 — Posted: 2021-01-29 Discussion: Onsite
The effect of SARS-CoV-2 variant B.1.1.7 on symptomatology, re-infection and transmissibility
Graham, M. S., Sudre, C. H., May, A., Antonelli, M., Murray, B., Varsavsky, T., Klaser, K., Canas, L. D. S., Molteni, E., Modat, M., Drew, D. A., Nguyen, L. A., Polidori, L., Selvachandran, S., Hu, C., Capdevila Pujol, J., The COVID-19 Genomics UK (COG-UK) consortium, , Hammers, A., Chan, A. T., Wolf, J., Spector, T., Steves, C., Ourselin, S.
10.1101/2021.01.28.21250680 — Posted: 2021-01-29
Evaluation of COVID-19 vaccination strategies with a delayed second dose
Moghadas, S. M., Vilches, T. N., Zhang, K., Nourbakhsh, S., Sah, P., Fitzpatrick, M. C., Galvani, A. P.
10.1101/2021.01.27.21250619 — Posted: 2021-01-29
Beyond the new normal: assessing the feasibility of vaccine-based elimination of SARS-CoV-2
Stoddard, M., Sarkar, S., Nolan, R. P., White, D. E., White, L., Hochberg, N. S., Chakravarty, A.
10.1101/2021.01.27.20240309 — Posted: 2021-01-29
The World Mortality Dataset: Tracking excess mortality across countries during the COVID-19 pandemic
Karlinsky, A., Kobak, D.
10.1101/2021.01.27.21250604 — Posted: 2021-01-29 Discussion: Onsite
A prediction model for COVID-19 prevalence based on demographic and healthcare parameters in Iran
Emadi Safavi, p. S., Rahimian, K., Doustmohammadi, A., Safari Dastjerdei, M., Rasouli, A., Zahiri, J.
10.1101/2021.01.27.21250551 — Posted: 2021-01-29
A Rapid and Low-Cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-Based RT-qPCR
Abdel-Sater, F., Younes, M., Nassar, H., Nguewa, P., Hamze, K.
10.1101/2021.01.27.21250048 — Posted: 2021-01-29
HLA-A*11:01:01:01, HLA*C*12:02:02:01-HLA-B*52:01:02:02, age and sex are associated with severity of Japanese COVID-19 with respiratory failure
Khor, S.-S., Omae, Y., Nishida, N., Sugiyama, M., Kinoshita, N., Suzuki, T., Suzuki, M., Suzuki, S., Izumi, S., Hojo, M., Ohmagari, N., Mizokami, M., Tokunaga, K.
10.1101/2021.01.26.21250349 — Posted: 2021-01-29
Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care
Klevebro, S., Bahram, F., Elfstrom, M. K., Hellberg, U., Hober, S., Merid, S. K., Kull, I., Nilsson, P., Tornvall, P., Wang, G., Conneryd-Lundgren, K., Ponzer, S., Dillner, J., Melen, E.
10.1101/2021.01.28.21250664 — Posted: 2021-01-29
SARS-CoV-2 in Ivory Coast: serosurveillance survey among mines workers
Milleliri, J.- M., Coulibaly, D., Nyobe, B., Rey, J.-L., Lamontagne, F., Hocqueloux, L., Giache, S., Valery, A., prazuck, t.
10.1101/2021.01.27.21249186 — Posted: 2021-01-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).